Mouse mammary tumor virus-like virus infection and the risk of human breast cancer: A meta-analysis

American Journal of Translational Research

Volumn 6, Issue 3, 2014, Pages 248-266

  Wang, Faliang ^a,b   Hou, Jinchao ^b   Shen, Qi ^a   Yue, Yongfang ^a   Xie, Fajun ^c   Wang, Xian ^a   Jin, Hongchuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Human breast cancer; MMTV LV; Mouse mammary tumor virus like virus

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER RISK; CELL HETEROGENEITY; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; INFORMATION PROCESSING; MOUSE MAMMARY TUMOR ONCOVIRUS; MOUSE MAMMARY TUMOR VIRUS LIKE VIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN EXPRESSION; PUBLISHING; QUALITY CONTROL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VIRUS INFECTION;

EID: 84901049157     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Parkin D. Cancer incidence in five continents. World Health Organization 2005.
2. Hunter DJ, Hankinson SE, Laden F, Colditz GA, Manson JE, Willett WC, Speizer FE and Wolff MS. Plasma organochlorine levels and the risk of breast cancer. New Engl J Med 1997; 337: 1253-1258.
3. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL and Rosenthal JF. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer I 1993; 85: 1819-1827.
4. Winter H, Cheng KK, Cummins C, Maric R, Sil-cocks P and Varghese C. Cancer incidence in the south Asian population of England (1990-92). Brit J Cancer 1999; 79: 645-654.
5. Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, Folsom AR, Fraser GE, Goldbohm RA, Graham S and Howe GR. Cohort studies of fat intake and the risk of breast cancer-a pooed analysis. New Engl J Med 1996; 334: 356-361.
6. Ayotte P, Dewailly E, Ryan J, Bruneau S andLebel G. PCBs and dioxin-like compounds inplasma of adult Inuit living in Nunavik (Arctic Quebec). Chemosphere 1997; 34: 1459-1468.
7. Miller AB and Gaudette LA. Breast cancer incircumpolar Inuit 1969-1988. Acta Oncol 1996; 35: 577-580.
8. Bittner JJ. Some possible effects of nursing onthe mammary gland tumor incidence in mice. Science 1936; 84: 162.
9. Poon MC, Tomana and Niedermeier W. Serumantibodies against mouse mammary tumor-virus-associated antigen detected nine months before appearance of a breast carcinoma. Ann Intern Med 1983; 98: 937-938.
10. Motamedifar M, Saki M and Ghaderi A. Lack ofassociation of mouse mammary tumor virus-like sequences in Iranian breast cancer patients. Med Princ Pract 2012; 21: 244-248.
11. Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ and Lawson JS. Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One 2012; 7: e48788.
12. Park DJ, Southey MC, Giles GG and Hopper JL. No evidence of MMTV-like env sequences inspecimens from the Australian Breast Cancer Family Study. Breast Cancer Res Treat 2011; 125: 229-235.
13. Mazzanti CM, Al Hamad M, Fanelli G, Scatena C, Zammarchi F, Zavaglia K, Lessi F, Pistello M, Naccarato AG and Bevilacqua G. A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma. Am J Pathol 2011; 179: 2083-2090.
14. Lawson JS, Glenn WK, Salmons B, Ye Y, Heng B, Moody P, Johal H, Rawlinson WD, Delprado W, Lutze-Mann L and Whitaker NJ. Mouse mammary tumor virus-like sequences in human breast cancer. Cancer Res 2010; 70: 3576-3585.
15. Mok MT, Lawson JS, Iacopetta BJ and Whitaker NJ. Mouse mammary tumor virus-like env se-quences in human breast cancer. Int J Cancer 2008; 122: 2864-2870.
16. Hachana M, Trimeche M, Ziadi S, Amara K, Gaddas N, Mokni M and Korbi S. Prevalenceand characteristics of the MMTV-like associated breast carcinomas in Tunisia. Cancer Lett 2008; 271: 222-230.
17. Zapata-Benavides P, Saavedra-Alonso S, Zamora-Avila D, Vargas-Rodarte C, Barrera-Rodriguez R, Salinas-Silva J, Rodriguez-Padilla C, Tamez-Guerra R and Trejo-Avila L. Mouse mammary tumor virus-like gene sequences in breast cancer samples of Mexican women. Intervirology 2007; 50: 402-407.
18. Zammarchi F, Pistello M, Piersigilli A, Murr R, Di Cristofano C, Naccarato AG and Bevilacqua G. MMTV-like sequences in human breast cancer: a fluorescent PCR/laser microdissection approach. J Pathol 2006; 209: 436-444.
19. Luo T, Wu XT, Zhang MM and Qian K. Study ofmouse mammary tumor virus-like gene sequences expressing in breast tumors of Chinese women. Sichuan Da Xue Xue Bao Yi Xue Ban 2006; 37: 844-846, 851.
20. Lawson JS, Tran DD, Carpenter E, Ford CE, Rawlinson WD, Whitaker NJ and Delprado W. Presence of mouse mammary tumour-like virus gene sequences may be associated with morphology of specific human breast cancer. J Clin Pathol 2006; 59: 1287-1292.
21. Levine PH, Pogo BGT, Klouj A, Coronel S, Wood-son K, Melana SM, Mourali N and Holland JF. Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer 2004; 101: 721-726.
22. Lawson JS, Tran DD, Ford C and Rawlinson WD. Elevated expression of the tumor suppressingprotein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer. Breast Cancer Res Treat 2004; 87: 13-17.
23. Ford CE, Faedo M, Crouch R, Lawson JS andRawlinson WD. Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women. Cancer Res 2004; 64: 4755-4759.
24. Faedo M, Ford CE, Mehta R, Blazek K and Raw-linson WD. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer. Clin Cancer Res 2004; 10: 4417-4419.
25. Etkind PR, Stewart AF, Dorai T, Purcell DJ andWiernik PH. Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies. Clin Cancer Res 2004; 10: 5656-5664.
26. Wang Y, Melana SM, Baker B, Bleiweiss I, Fer-nandez-Cobo M, Mandeli JF, Holland JF andPogo BG. High prevalence of MMTV-like env gene sequences in gestational breast cancer. Med Oncol 2003; 20: 233-236.
27. Ford CE, Tran D, Deng Y, Ta VT, Rawlinson WDand Lawson JS. Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clin Cancer Res 2003; 9: 1118-1120.
28. Melana SM, Picconi MA, Rossi C, Mural J, Alo-nio LV, Teyssié A, Holland JF and Pogo BG. De-tection of murine mammary tumor virus (MMTV) env gene-like sequences in breast cancer from Argentine patients. Medicina (B Aires) 2002; 62: 323-327.
29. Wang Y, Pelisson I, Melana SM, Holland JF andPogo BG. Detection of MMTV-like LTR and LTR-env gene sequences in human breast cancer. Int J Oncol 2001; 18: 1041-1044.
30. Wang Y, Pelisson I, Melana SM, Go V, Holland JF and Pogo BG. MMTV-like env gene sequenc-es in human breast cancer. Arch Virol 2001; 146: 171-180.
31. Melana SM, Holland JF and Pogo BG. Searchfor mouse mammary tumor virus-like env se-quences in cancer and normal breast from the same individuals. Clin Cancer Res 2001; 7: 283-284.
32. Etkind P, Du J, Khan A, Pillitteri J and Wiernik PH. Mouse mammary tumor virus-like ENVgene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res 2000; 6: 1273-1278.
33. Pogo BG, Melana SM, Holland JF, Mandeli JF, Pilotti S, Casalini P and Menard S. Sequenceshomologous to the mouse mammary tumor virus env gene in human breast carcinoma correlate with overexpression of laminin receptor. Clin Cancer Res 1999; 5: 2108-2111.
34. Wang Y, Holland JF, Bleiweiss IJ, Melana S, Liu X, Pelisson I, Cantarella A, Stellrecht K, Mani Sand Pogo BG. Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res 1995; 55: 5173-5179.
35. JPT CHH and Green S. Cochrane handbook forsystematic reviews of interventions version5.1. 0 [updated March 2011]. The Cochrane Collaboration 2011.
36. Moher D, Liberati A, Tetzlaff J and Altman DG. Preferred reporting items for systematic re-views and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269.
37. Mant C, Gillett C, D'Arrigo C and Cason J. Hu-man murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies. Virology 2004; 318: 393-404.
38. Glenn WK, Lawson JS and Whitaker NJ. Mousemammary tumour-like virus gene sequencesand specific breast cancer morphology. J Clin Pathol 2007; 60: 1071.
39. Etkind PR, Stewart AF and Wiernik PH. Mousemammary tumor virus (MMTV)-like DNA se-quences in the breast tumors of father, mother, and daughter. Infect Agent Cancer 2008; 3: 2.
40. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
41. Mantel N and Haenszel W. Statistical aspectsof the analysis of data from retrospective stud-ies of disease. J Natl Cancer Inst 1959; 22: 719-748.
42. DerSimonian R and Kacker R. Random-effectsmodel for meta-analysis of clinical trials: an up-date. Contemp Clin Trials 2007; 28: 105-114.
43. Higgins JP, Thompson SG, Deeks JJ and Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
44. Kanwal F and White D. "Systematic Reviewsand Meta-analyses" in Clinical Gastroenterolo-gy and Hepatology. Clin Gastroenterol Hepatol 2012; 10: 1184-1186.
45. Egger M, Smith GD, Schneider M and Minder C. Bias in meta-analysis detected by a simple,graphical test. Bmj 1997; 315: 629-634.
46. Easterbrook PJ, Gopalan R, Berlin JA and Mat-thews DR. Publication bias in clinical research. Lancet 1991; 337: 867-872.
47. Morales-Sanchez A, Molina-Munoz T, Martinez-Lopez JL, Hernandez-Sancen P, Mantilla A, Leal YA, Torres J and Fuentes-Panana EM. No association between Epstein-Barr Virus and Mouse Mammary Tumor Virus with Breast Cancer in Mexican Women. Sci Rep 2013; 3: 2970.
48. Tabriz HM, Zendehdel K, Shahsiah R, Fereido-oni F, Mehdipour B and Hosseini ZM. Lack of Detection of the Mouse Mammary Tumor-like Virus (MMTV) Env Gene in Iranian Women Breast Cancer using Real Time PCR. Asian Pac J Cancer Prev 2013; 14: 2945-2948.
49. Ohno T, Mesa-Tejada R, Keydar I, Ramanaray-anan M, Bausch J and Spiegelman S. Humanbreast carcinoma antigen is immunologically related to the polypeptide of the group-specific glycoprotein of mouse mammary tumor virus. Proc Natl Acad Sci U S A 1979; 76: 2460-2464.
50. Witkin SS, Sarkar NH, Kinne DW, Good RA andDay NK. Antibodies reactive with the mouse mammary tumor virus in sera of breast cancer patients. Int J Cancer 1980; 25: 721-725.
51. Moore DH, Charney J, Kramarsky B, Lasfar-gues EY, Sarkar NH, Brennan MJ, Burrows JH, Sirsat SM, Paymaster JC and Vaidya AB. Search for a human breast cancer virus. Nature 1971; 229: 611-614.
52. May FE, Westley BR, Rochefort H, Buetti E andDiggelmann H. Mouse mammary tumour virusrelated sequences are present in human DNA. Nucleic Acids Res 1983; 11: 4127-4139.
53. Althuis MD, Dozier JM, Anderson WF, Devesa SS and Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005; 34: 405-412.
54. Parkin D, Whelan S, Raymond L and Young J. Cancer incidence in five continents. Vol 7 1997.
55. Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF and Pogo BG. Identification of aproviral structure in human breast cancer. Cancer Res 2001; 61: 1754-1759.
56. Callahan R and Smith GH. MMTV-inducedmammary tumorigenesis: gene discovery, pro-gression to malignancy and cellular pathways. Oncogene 2000; 19: 992-1001.
57. Faschinger A, Rouault F, Sollner J, Lukas A, Salmons B, Günzburg WH and Indik S. Mousemammary tumor virus integration site selection in human and mouse genomes. J Virol 2008; 82: 1360-1367.
58. Golovkina T, Prescott J and Ross S. Mousemammary tumor virus-induced tumorigenesisin sag transgenic mice: a laboratory model of natural selection. J Virol 1993; 67: 7690-7694.
59. Ross SR, Schmidt JW, Katz E, Cappelli L, Hul-tine S, Gimotty P and Monroe JG. An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors. J Virol 2006; 80: 9000-9008.
60. Stewart TH, Sage RD, Stewart AF and Cameron DW. Breast cancer incidence highest in therange of one species of house mouse, Mus domesticus. Br J Cancer 2000; 82: 446-451.
61. Sage RD, Atchley WR and Capanna E. Housemice as models in systematic biology. Syst Biol 1993; 42: 523-561.
62. Szabo S, Haislip AM and Garry RF. Of mice,cats, and men: is human breast cancer a zoo-nosis? Microsc Res Tech 2005; 68: 197-208.
63. Kihara AH, Moriscot AS, Ferreira PJ and Hamas-saki DE. Protecting RNA in fixed tissue: an alternative method for LCM users. J Neurosci Methods 2005; 148: 103-107.
64. Cammarota G, Da Prato L, Nicoletti E, Matteucci D, Bendinelli M and Pistello M. Quantitationof feline immunodeficiency provinsses in doubly infected cats using competitive PCR and a fluorescence-based RFLP. J Virol Methods 1996; 62: 21-31.
65. Butler JM, McCord BR, Jung JM, Wilson MR, Budowle B and Allen RO. Quantitation of poly-merase chain reaction products by capillary electrophoresis using laser fluorescence. J Chromatogr B Biomed Appl 1994; 658: 271-280.